Symbol: CIPLA
Month: 2024-05
Start Price: ₹1408.11
End Price: ₹1435.03
12M Return: 1.91%
6M Return: 1.91%
3M Return: 1.91%
Volatility: 0.364
Sharpe Ratio: 0.827
Max Drawdown: -0.060
Peer Correlation (SUNPHARMA): 0.1502
Peer Correlation (DIVISLAB): 0.5792
Peer Correlation (GRASIM): 0.2294
Average Peer Correlation: 0.3196

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

Cipla's stock performance has been relatively stable, with a modest 1.91% return over the past 12 months, 6 months, and 3 months. The volatility of the stock is relatively low at 0.364, indicating a lower risk profile. The Sharpe Ratio of 0.827 suggests that the returns are relatively high compared to the risk taken. The maximum drawdown of -0.060 indicates that the stock has not experienced a significant decline in value. In terms of peer correlation, Cipla has a moderate correlation with its peers, with the highest correlation being with DivisLab (0.5792).

**Recommendation:**

Based on the analysis, I would suggest a **HOLD** recommendation for Cipla. The stock's stable performance and low volatility make it an attractive option for risk-averse investors. The Sharpe Ratio indicates that the returns are relatively high compared to the risk taken, which is a positive sign. However, the peer correlation analysis suggests that Cipla's performance is not significantly different from its peers, which may limit its upside potential. Therefore, a hold recommendation is warranted, as the stock is expected to continue its stable performance, but may not offer significant growth opportunities.